| 04.12.2024 12:18 | FAB | Fusion Antibodies receives approval of grant funding application | Alliance |
| 04.12.2024 11:31 | FAB | Approval of Grant Funding Application | RNS |
| 19.11.2024 13:10 | FAB | Fusion Antibodies interim loss narrows as revenue more than doubles | Alliance |
| 16.10.2024 13:23 | FAB | Director/PDMR Shareholding | RNS |
| 16.10.2024 07:00 | FAB | Issue of shares to non-executive directors | RNS |
| 08.10.2024 13:58 | FAB | IN BRIEF: Fusion Antibodies expects interim revenue to double | Alliance |
| 08.10.2024 12:32 | FAB | Result of AGM | RNS |
| 08.10.2024 07:00 | FAB | AGM statement and trading update | RNS |
| 02.10.2024 07:00 | FAB | Block admission six monthly return | RNS |
| 01.10.2024 15:33 | LGRS, FAB | UK shareholder meetings calendar - next 7 days | Alliance |
| 12.09.2024 09:54 | FAB | Notice of AGM | RNS |
| 09.09.2024 12:35 | FAB | Director/PDMR Shareholding | RNS |
| 09.09.2024 07:00 | FAB | Investor presentation | Reach |
| 05.09.2024 12:15 | FAB | Director/PDMR Shareholding | RNS |
| 05.09.2024 07:00 | FAB | Final Results | RNS |
| 28.08.2024 13:52 | FAB | Fusion Antibodies expands agreement with National Cancer Institute | Alliance |
| 28.08.2024 11:12 | TYM, AQX, FAB | AIM WINNERS & LOSERS: Aquis expects GBP1 million hit on contract loss | Alliance |
| 28.08.2024 07:00 | FAB | Expansion to OptiMAL collaboration agreement | Reach |
| 22.07.2024 12:54 | FAB | Director/PDMR Shareholding | RNS |
| 18.07.2024 07:00 | FAB | Launch of New Interactive Investor Hub | Reach |
| 04.07.2024 13:33 | ECOB, REE, FAB | TRADING UPDATES: itim signs contract; Tekmar renews banking facilities | Alliance |
| 04.07.2024 07:00 | FAB | Trading update | RNS |
| 23.05.2024 21:08 | CEL, AET, PHAR | TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact | Alliance |
| 23.05.2024 07:00 | FAB | New contract with existing client | RNS |
| 02.05.2024 07:00 | FAB | Investor presentation | Reach |
| 30.04.2024 19:54 | TAND, IGE, CHL | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | Alliance |
| 30.04.2024 07:00 | FAB | Year-end trading statement | RNS |
| 16.04.2024 07:00 | FAB | Change of auditor | RNS |
| 15.04.2024 13:29 | FAB | Fusion Antibodies inks commercial contract for OptiPhage library | Alliance |
| 15.04.2024 07:00 | FAB | Contract to develop a bespoke OptiPhage library | RNS |
| 02.04.2024 14:34 | FAB | Block admission six monthly return | RNS |
| 28.03.2024 17:00 | FAB | Total Voting Rights | RNS |
| 11.03.2024 15:04 | FAB | Holding(s) in Company | RNS |
| 11.03.2024 09:10 | FAB | Holding(s) in Company | RNS |
| 08.03.2024 15:09 | FAB | Holding(s) in Company | RNS |
| 05.03.2024 10:40 | FAB | Result of General Meeting and Total Voting Rights | RNS |
| 29.02.2024 17:00 | FAB | Total Voting Rights | RNS |
| 27.02.2024 14:18 | CDL, DXRX, UOG | TRADING UPDATES: Sondrel wins USD23 million contract | Alliance |
| 27.02.2024 07:00 | FAB | First purchase order under MSA | RNS |
| 14.02.2024 11:27 | FAB | IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing | Alliance |
| 14.02.2024 07:15 | FAB | Grant of options and issue of shares to directors | RNS |
| 14.02.2024 07:00 | FAB | Placing to raise £1,375,000 | RNS |
| 06.02.2024 11:48 | FAB | Fusion Antibodies strikes follow-on research and development project | Alliance |
| 06.02.2024 10:05 | PCIP, FAB, BKS | AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations | Alliance |
| 01.02.2024 12:00 | FAB | Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform | Alliance |
| 04.12.2023 12:26 | FAB | Director/PDMR Shareholding | RNS |
| 04.12.2023 10:23 | FAB, DEMG | AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations | Alliance |
| 04.12.2023 10:22 | FAB | Fusion Antibodies shares fall with revenue despite "positive" outlook | Alliance |
| 04.12.2023 07:00 | FAB | Half-year Report | RNS |
| 28.11.2023 12:09 | FAB | Fusion Antibodies shares up on deal with US National Cancer Institute | Alliance |
| 28.11.2023 10:33 | SUP, TLY, FAB | AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow | Alliance |
| 28.11.2023 07:00 | FAB | OptiMAL collaboration agreement | RNS |
| 09.11.2023 12:54 | GENL, KDNC, EMH | EARNINGS AND TRADING: Wincanton profit down; James Cropper ups payout | Alliance |
| 09.11.2023 07:00 | FAB | Half year trading update | RNS |
| 27.10.2023 11:57 | FAB | Result of AGM | RNS |
| 04.10.2023 14:45 | FAB | Block admission six monthly return | RNS |
| 29.09.2023 21:19 | KEN, FAB, CPX | EARNINGS: Tan Delta revenue jumps; Kendrick Resources loss widens | Alliance |
| 29.09.2023 07:00 | FAB | Final Results | RNS |
| 29.08.2023 07:00 | FAB | Update on AI/ML-Ab service offering | RNS |
| 24.08.2023 12:10 | FAB | IN BRIEF: Fusion Antibodies appoints part-time CFO on cash struggles | Alliance |
| 24.08.2023 07:00 | FAB | Appointment of interim CFO | RNS |
| 21.08.2023 10:29 | FAB | AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens | Alliance |
| 21.08.2023 09:35 | FAB | Fusion Antibodies inks deal with AI learning firm, hails lower costs | Alliance |
| 21.08.2023 07:00 | FAB | Update on AI/ML-Ab™ antibody discovery service | RNS |
| 14.08.2023 08:41 | FAB | Fusion Antibodies completes "difficult" restructuring | Alliance |
| 14.08.2023 07:00 | FAB | Update on restructure and cost savings | RNS |
| 30.06.2023 17:00 | FAB | Total Voting Rights | RNS |
| 16.06.2023 10:09 | FAB | Holding(s) in Company | RNS |
| 15.06.2023 09:45 | FAB | Holding(s) in Company | RNS |
| 13.06.2023 14:44 | FAB | Holding(s) in Company | RNS |
| 12.06.2023 15:34 | FAB | Holding(s) in Company | RNS |
| 12.06.2023 11:02 | FAB | Director/PDMR Shareholding | RNS |
| 08.06.2023 10:39 | FAB | Result of GM and total voting rights | RNS |
| 01.06.2023 15:52 | EGY, RENX, PALM | UK shareholder meetings calendar - next 7 days | Alliance |
| 31.05.2023 17:00 | FAB | Total Voting Rights | RNS |
